Xcout Intel
Brio Health, Inc.
BrioHealth Solutions develops medical technology for the treatment of advanced heart failure. The company's primary product is the BrioVAD system, an investigational Left Ventricular Assist System (LVAS) designed to improve the quality of life for heart failure patients.
Subscribe to see Brio Health, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Brio Health, Inc. at a glance
Brio Health, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $93,000 in July 2026. Xcout tracks 6 named people at Brio Health, Inc., including Chen Chen (CEO).
Brio Health, Inc. leadership
- Chen ChenCEO
- Alex LuCFO
- Geoff BakerVP, Clinical Market Development
- Lydia SakakeenyVP, US Regulatory Affairs
- Pranesh ThirukkondaVP, Clinical and Field Support
- Yan GongVP, Human Resources
Brio Health, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $93,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Brio Health, Inc. news
- FundingPrivate placement (Form D)
Brio Health, Inc. competitors
A few of Brio Health, Inc.'s closest competitors — see the full list of competitors and alternatives →
Corvion Inc., formerly known as EverHeart Systems, is headquartered in Webster, Texas, and develops fully implanted mechanical circulatory support devices. Its flagship product, the Corvion LVAD, is designed to serve as a successful circulatory support device for severe heart failure.
V-Wave is a medical technology company established in Israel in 2009 that develops percutaneous implantable shunts and technologies for patients with chronic heart failure.
BioVentrix, Inc. is a privately held specialty medical device company headquartered in Mansfield, Massachusetts. The firm serves cardiothoracic surgeons and patients by developing lifesaving therapies for heart failure.
BiVACOR, Inc. is a clinical-stage medical device company founded in 2008 that pioneers the development of a total artificial heart to replace failing hearts and restore patient lives. The company is headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international facilities in Australia.
Procyrion, Inc. is a Houston, Texas-based heart pump developer. The company focuses on the research, expansion, and development of its Aortix circulatory support device for investigational use.
Get Brio Health, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Brio Health, Inc. in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access